Rapid Micro Biosystems Stock Net Income
| RPID Stock | USD 1.05 0.06 6.06% |
Rapid Micro Biosystems fundamentals help investors to digest information that contributes to Rapid Micro's financial success or failures. It also enables traders to predict the movement of Rapid Stock. The fundamental analysis module provides a way to measure Rapid Micro's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rapid Micro stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -60.7 M | -63.7 M | |
| Net Loss | -54.7 M | -57.5 M | |
| Net Loss | -52.5 M | -55.1 M | |
| Net Loss | (1.22) | (1.28) | |
| Net Income Per E B T | 1.00 | 1.10 |
Rapid | Net Income |
Rapid Micro Biosystems Company Net Income Analysis
Rapid Micro's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Rapid Micro Net Income | (52.47 M) |
Most of Rapid Micro's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rapid Micro Biosystems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Rapid Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Rapid Micro is extremely important. It helps to project a fair market value of Rapid Stock properly, considering its historical fundamentals such as Net Income. Since Rapid Micro's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Rapid Micro's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Rapid Micro's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Rapid Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Rapid Micro Biosystems reported net income of (52.47 Million). This is 115.37% lower than that of the Wireless Telecommunication Services sector and 122.03% lower than that of the Communication Services industry. The net income for all United States stocks is 109.19% higher than that of the company.
Rapid Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rapid Micro's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Rapid Micro could also be used in its relative valuation, which is a method of valuing Rapid Micro by comparing valuation metrics of similar companies.Rapid Micro is currently under evaluation in net income category among its peers.
Rapid Micro Institutional Holders
Institutional Holdings refers to the ownership stake in Rapid Micro that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Rapid Micro's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Rapid Micro's value.| Shares | State Street Corp | 2024-06-30 | 26.1 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 20.2 K | Northern Trust Corp | 2024-09-30 | 15.6 K | Xtx Topco Ltd | 2024-09-30 | 14.5 K | Two Sigma Securities, Llc | 2024-06-30 | 11 K | Tower Research Capital Llc | 2024-06-30 | 8.3 K | Resources Management Corp /ct/ /adv | 2024-06-30 | 500 | Royal Bank Of Canada | 2024-06-30 | 442 | Bank Of America Corp | 2024-06-30 | 164 | Bain Capital Life Sciences Investors, Llc | 2024-09-30 | 8.4 M | Kennedy Lewis Management Lp | 2024-09-30 | 4.9 M |
Rapid Fundamentals
| Return On Equity | -0.46 | ||||
| Return On Asset | -0.25 | ||||
| Profit Margin | (1.85) % | ||||
| Operating Margin | (1.58) % | ||||
| Current Valuation | (11.77 M) | ||||
| Shares Outstanding | 37.72 M | ||||
| Shares Owned By Insiders | 8.53 % | ||||
| Shares Owned By Institutions | 57.65 % | ||||
| Number Of Shares Shorted | 44.05 K | ||||
| Price To Book | 0.51 X | ||||
| Price To Sales | 1.63 X | ||||
| Revenue | 22.52 M | ||||
| Gross Profit | (8.54 M) | ||||
| EBITDA | (53.76 M) | ||||
| Net Income | (52.47 M) | ||||
| Cash And Equivalents | 145.1 M | ||||
| Cash Per Share | 3.46 X | ||||
| Total Debt | 7.35 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 13.45 X | ||||
| Book Value Per Share | 1.93 X | ||||
| Cash Flow From Operations | (45.08 M) | ||||
| Short Ratio | 0.39 X | ||||
| Earnings Per Share | (1.12) X | ||||
| Target Price | 8.0 | ||||
| Number Of Employees | 193 | ||||
| Beta | 1.08 | ||||
| Market Capitalization | 42.61 M | ||||
| Total Asset | 143.45 M | ||||
| Retained Earnings | (428.38 M) | ||||
| Working Capital | 101.43 M | ||||
| Current Asset | 217 K | ||||
| Current Liabilities | 6.84 M | ||||
| Net Asset | 143.45 M |
About Rapid Micro Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rapid Micro Biosystems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rapid Micro using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rapid Micro Biosystems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Rapid Micro Biosystems is a strong investment it is important to analyze Rapid Micro's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Rapid Micro's future performance. For an informed investment choice regarding Rapid Stock, refer to the following important reports:Check out Rapid Micro Piotroski F Score and Rapid Micro Altman Z Score analysis. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Wireless Telecommunication Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rapid Micro. If investors know Rapid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rapid Micro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share 0.603 | Quarterly Revenue Growth 0.237 | Return On Assets (0.25) | Return On Equity (0.46) |
The market value of Rapid Micro Biosystems is measured differently than its book value, which is the value of Rapid that is recorded on the company's balance sheet. Investors also form their own opinion of Rapid Micro's value that differs from its market value or its book value, called intrinsic value, which is Rapid Micro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rapid Micro's market value can be influenced by many factors that don't directly affect Rapid Micro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rapid Micro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rapid Micro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rapid Micro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.